[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (249)

Search Parameters:
Keywords = prescription trends

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
12 pages, 1350 KiB  
Article
Evolution of Fentanyl Prescription Patterns and Administration Routes in Primary Care in Salamanca, Spain: A Comprehensive Analysis from 2011 to 2022
by Cristina Torres-Bueno, Mercedes Sanchez-Barba, Jose-Antonio Miron-Canelo and Veronica Gonzalez-Nunez
Healthcare 2024, 12(16), 1619; https://doi.org/10.3390/healthcare12161619 - 14 Aug 2024
Abstract
(1) Background: The escalating use of opioids contributes to social, health, and economic crises. In Spain, a notable surge in the medical prescription of opioids in recent years has been observed. The aim of this work was to assess the consumption rate of [...] Read more.
(1) Background: The escalating use of opioids contributes to social, health, and economic crises. In Spain, a notable surge in the medical prescription of opioids in recent years has been observed. The aim of this work was to assess the consumption rate of fentanyl, categorised by the different administration routes, in Primary Care in the province of Salamanca (Spain) spanning the years 2011 to 2022, and to compare it with the national trend and with data from the US. (2) Methods: Doses per inhabitant per day (DHD) were calculated, and interannual variations, as well as consumption rates, were subject to thorough analysis. (3) Results: The prevalence of fentanyl use in Salamanca has doubled from 1.21 DHD in 2011 to 2.56 DHD in 2022, with the transdermal system (TD) as the predominant administration route. This upward trajectory mirrors the national trend, yet the rise in fentanyl use is markedly lower than the reported data in the US. This finding may be attributed to an ageing population and potentially inappropriate fentanyl prescriptions, i.e., for the management of chronic non-cancer pain and other off-label prescriptions. (4) Conclusions: The use of fentanyl in Salamanca, particularly through transdermal systems, doubled from 2011 to 2022, aligning with the national trend. Preventive measures are imperative to prevent fentanyl misuse and moderate the observed escalation in consumption rates. Full article
(This article belongs to the Section Pain Management)
Show Figures

Figure 1

Figure 1
<p>Prevalence of fentanyl use in the Spanish province of Salamanca between 2011 and 2022. DHD data are shown for total fentanyl use as well as by route of administration (transdermal, buccal, nasal, and sublingual).</p>
Full article ">Figure 2
<p>Distribution of fentanyl use by route of administration in the province of Salamanca between 2011 and 2022, expressed as percentage of total consumption. The majority of fentanyl prescriptions are for transdermal use, which also increases over the years to the detriment of the oral route.</p>
Full article ">Figure 3
<p>Change in fentanyl use in the province of Salamanca between 2011 and 2022, expressed as percentage of variation in DHDs compared to 2011. Data are calculated for total fentanyl prescriptions, as well as for transdermal and oral formulations. There is a significant increase in the use of fentanyl, mainly due to the transdermal route, while the use of the oral formulation has remained constant.</p>
Full article ">Figure 4
<p>Prevalence of fentanyl use in the Spanish province of Salamanca and in Spain between 2011 and 2022.</p>
Full article ">Figure 5
<p>Comparison of the prevalence of fentanyl use in Salamanca and the US, expressed as a percentage (‰) of users in the total population. US data are from the National Survey on Drug Use and Health (NSDUH) of the Substance Abuse and Mental Health Services Administration (SAMHSA). There is an upward trend for total fentanyl use in both Salamanca and in the US.</p>
Full article ">
12 pages, 529 KiB  
Article
National 30-Day Readmission Trends in IBD 2014–2020—Are We Aiming for Improvement?
by Irēna Teterina, Veronika Mirzajanova, Viktorija Mokricka, Maksims Zolovs, Dins Šmits and Juris Pokrotnieks
Medicina 2024, 60(8), 1310; https://doi.org/10.3390/medicina60081310 - 13 Aug 2024
Viewed by 385
Abstract
Background: Inflammatory bowel disease (IBD) prevalence in Eastern Europe is increasing. The 30-day readmission rate is a crucial quality metric in healthcare, reflecting the effectiveness of initial treatment and the continuity of care post-discharge; however, such parameters are rarely analyzed. The aim of [...] Read more.
Background: Inflammatory bowel disease (IBD) prevalence in Eastern Europe is increasing. The 30-day readmission rate is a crucial quality metric in healthcare, reflecting the effectiveness of initial treatment and the continuity of care post-discharge; however, such parameters are rarely analyzed. The aim of this study was to explore the trends in 30-day readmissions among patients with inflammatory bowel disease in Latvia between 2014 and 2020. Methods: This is a retrospective trends study in IBD—ulcerative colitis and Crohn’s disease (UC and CD)—patients in Latvia between 2014 and 2020, involving all IBD patients identified in the National Health service database in the International Classification of Diseases-10 (ICD) classification (K50.X and K51.X) and having at least one prescription for IBD diagnoses. We assessed all IBD-related hospitalizations (discharge ICD codes K50X and K51X), as well as hospitalizations potentially related to IBD comorbidities. We analyzed hospitalization trends and obtained the 30 day all-cause readmission rate, disease specific readmission rate and readmission proportion for specific calendar years. Trends in readmissions and the mean length of stay (LOS) for CD and UC were calculated. Results: Despite a decrease in admission rates observed in 2020, the total number of readmissions for CD and UC has increased. Female patients prevailed through the study period and were significantly older than male patients in both the CD and UC groups, p < 0.05. We noted that there was no trend for 30 day all-cause readmission rate for CD (p > 0.05); however, there was a statistically significant trend for 30 day all-cause readmission for UC patients (p-trend = 0.018) in the period from 2014 to 2019. There was a statistically significant trend for CD-specific readmission rate (p < 0.05); however, no statistically significant trend was observed for UC-specific readmission (p > 0.05). An exploratory analysis did not reveal any statistically significant differences between treated and not-treated IBD patients (p > 0.05). The increasing trend is statistically significant over the period 2014–2018 (p < 0.05); however, the trend interrupts in 2020, which can be associated with the COVID-19 global pandemic and the related changes in admission flows where the gastroenterology capacity was reallocated to accommodate increasing numbers of COVID-19 patients. More studies are needed to evaluate the long-term impact of COVID-19 pandemic and 30-day readmissions. No significant dynamics were observed in the mean total hospitalization costs over the 2014–2020 period. Full article
(This article belongs to the Section Gastroenterology & Hepatology)
Show Figures

Figure 1

Figure 1
<p>Trends of 30 day readmission following Crohn’s disease and ulcerative colitis hospitalizations. Abbreviations: CD—Crohn’s disease, UC—ulcerative colitis.</p>
Full article ">
15 pages, 3653 KiB  
Article
Patterns of Antibiotic Prescription in Endodontic Therapy in the Republic of Croatia
by Josipa Sović, Sanja Šegović, Božidar Pavelić, Ivona Bago, Ivana Šutej and Ivan Tomašić
Antibiotics 2024, 13(7), 645; https://doi.org/10.3390/antibiotics13070645 - 12 Jul 2024
Viewed by 487
Abstract
In response to the global trend of decreasing antibiotic usage, this study aimed to evaluate the nature and frequency of antibiotic prescriptions in conjunction with endodontic therapy in Croatia and to assess the attitudes of Croatian dental practitioners towards the endodontic treatment of [...] Read more.
In response to the global trend of decreasing antibiotic usage, this study aimed to evaluate the nature and frequency of antibiotic prescriptions in conjunction with endodontic therapy in Croatia and to assess the attitudes of Croatian dental practitioners towards the endodontic treatment of patients susceptible to bacterial endocarditis. A survey questionnaire was sent to all dental practitioners in Croatia, achieving a response rate of 27%. The most frequently prescribed antibiotic was penicillin with clavulanic acid (63.4%), while standalone penicillin was less prevalent (18.6%). For patients exhibiting penicillin allergies, 90% of respondents indicated clindamycin as their preferred alternative. Antibiotics were mostly prescribed for localized acute apical abscesses without fever, followed by prophylaxis for infectious endocarditis and cellulitis. Only 1.3% of the respondents reported frequent antibiotic prescriptions without accompanying local treatment. While a substantial proportion of surveyed practitioners professed familiarity with the latest guidelines for antibiotic prophylaxis, their choice of antibiotics did not consistently reflect this claim. Most respondents conducted endodontic procedures on patients at risk of bacterial endocarditis. The findings highlight a need for targeted continuing education for dental practitioners in the Republic of Croatia, ensuring their practices align with current guidelines and global trends in antibiotic prescription. Full article
(This article belongs to the Special Issue Antibiotic Prescribing in Primary Dental Care)
Show Figures

Figure 1

Figure 1
<p>General characteristics of practitioners. (<b>A</b>) Years in practice; (<b>B</b>) continuing dental education on endodontics in the last 5 years (CE); and (<b>C</b>) degree of clinical education (DCE) of the responders (Doctor of Dental Medicine; Specialist in Endodontics; Resident in Endodontics).</p>
Full article ">Figure 2
<p>Effect of various factors on antibiotic prescription. (<b>A</b>) Effect of sex and years of practice of dental practitioners; (<b>B</b>) effect of continuing dental education in endodontics taken by dental practitioners in the last 5 years (CE); (<b>C</b>) effect of educational qualifications of the dental practitioner; (<b>D</b>) effect of office organization; (<b>E</b>) effect of office type; (<b>F</b>) effect of rubber dam use; (<b>G</b>) effect of “single-visit endodontic treatment”. (Significance codes used are: ** for 0.01, * for 0.05, dot for 0.1. Slopes are designated with corresponding number of stripes whereas a dotted stripe corresponds to a dot, i.e., to 0.1 significance).</p>
Full article ">Figure 3
<p>Categorization of dentists prescribing antibiotics for various endodontic etiologies according to sex and educational qualifications. DDM, Doctor of Dental Medicine without specialization; EndoS, Specialist in Endodontics; EndoR, Resident in Endodontics.</p>
Full article ">Figure 4
<p>Proportion of dentists prescribing antibiotics without performing treatment on the affected tooth. (<b>A</b>) Effect of sex and years of practice of dental practitioners on antibiotic prescription; (<b>B</b>) effect of continuing dental education on endodontics taken by dental practitioners in the last 5 years (CE) on antibiotic prescription; (<b>C</b>) effect of educational qualifications of the dental practitioner on antibiotic prescription; (<b>D</b>) effect of office organization on antibiotic prescription; (<b>E</b>) effect of office type on antibiotic prescription; (<b>F</b>) effect of rubber dam use on antibiotic prescription. HC, health center; Conc, dental clinic with concession contract; Priv, private clinic; PrivSA, private clinic with a health fund contract; Poly, dental polyclinic; SDM, school of dental medicine; DDM, Doctor of Dental Medicine without specialization; EndoS, Specialist in Endodontics; EndoR, Resident in Endodontics. (Significance codes used are: *** for 0.001, * for 0.05, Slopes are designated with corresponding number of stripes).</p>
Full article ">Figure 5
<p>Categorization of dentists willing to perform endodontic treatment in patients at risk of infective endocarditis. (<b>A</b>) Effect of sex and years of practice of dental practitioners on antibiotic prescription; (<b>B</b>) effect of continuing dental education on endodontics taken by dental practitioners in the last 5 years (CE) on antibiotic prescription; (<b>C</b>) effect of educational qualifications of the dental practitioner on antibiotic prescription; (<b>D</b>) effect of office organization on antibiotic prescription; (<b>E</b>) effect of office type on antibiotic prescription; (<b>F</b>) effect of rubber dam use on antibiotic prescription; (<b>G</b>) effect of “single-visit endodontic treatment” on antibiotic prescription. HC, health center; Conc, dental clinic with concession contract; Priv, private clinic; PrivSA, private clinic with a health fund contract; Poly, dental polyclinic; SDM, school of dental medicine; DDM, Doctor of Dental Medicine without specialization; EndoS, Specialist in Endodontics; EndoR, Resident in Endodontics. (Significance codes used are: *** for 0.001, ** for 0.01, * for 0.05, dot for 0.1. Slopes are designated with corresponding number of stripes whereas a dotted stripe corresponds to a dot, i.e., to 0.1 significance).</p>
Full article ">
15 pages, 5410 KiB  
Article
Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017–2021): Insights into Rising Deaths in High-Risk Areas
by Amirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Eda Kemahlioglu-Ziya and Robert Handfield
Healthcare 2024, 12(13), 1268; https://doi.org/10.3390/healthcare12131268 - 26 Jun 2024
Viewed by 950
Abstract
With opioid overdose rates on the rise, we aimed to develop a county-level risk stratification that specifically focused on access to medications for opioid use disorder (MOUDs) and high overdose rates. We examined over 15 million records from the South Carolina Prescription Tracking [...] Read more.
With opioid overdose rates on the rise, we aimed to develop a county-level risk stratification that specifically focused on access to medications for opioid use disorder (MOUDs) and high overdose rates. We examined over 15 million records from the South Carolina Prescription Tracking System (SCRIPTS) across 46 counties. Additionally, we incorporated data from opioid treatment programs, healthcare professionals prescribing naltrexone, clinicians with buprenorphine waivers, and county-level overdose fatality statistics. To assess the risk of opioid misuse, we classified counties into high-risk and low-risk categories based on their prescription rates, overdose fatalities, and treatment service availability. Statistical methods employed included the two-sample t-test and linear regression. The t-test assessed the differences in per capita prescription rates between high-risk and low-risk counties. Linear regression was used to analyze the trends over time. Our study showed that between 2017 and 2021, opioid prescriptions decreased from 64,223 to 41,214 per 100,000 residents, while fentanyl-related overdose deaths increased by 312%. High-risk counties had significantly higher rates of fentanyl prescriptions and relied more on out-of-state doctors. They also exhibited higher instances of doctor shopping and had fewer medical doctors per capita, with limited access to MOUDs. To effectively combat the opioid crisis, we advocate for improved local healthcare infrastructure, broader treatment access, stricter management of out-of-state prescriptions, and vigilant tracking of prescription patterns. Tailored local strategies are essential for mitigating the opioid epidemic in these communities. Full article
(This article belongs to the Section Health Policy)
Show Figures

Figure 1

Figure 1
<p>Risk statuses of counties in South Carolina.</p>
Full article ">Figure 2
<p>Temporal trend of county-level overdose by underlying cause of death during years 2017 to 2021—state of South Carolina.</p>
Full article ">Figure 3
<p>Monthly Per capita prescription differences between patients in high-risk and low-risk counties: drug type and prescriber location. In the graph, statistical significance is indicated next to the slope values as follows: ‘***’ for highly significant differences (<math display="inline"><semantics> <mrow> <mi>p</mi> <mo>≤</mo> <mn>0.001</mn> </mrow> </semantics></math>).</p>
Full article ">Figure 4
<p>Monthly per capita prescription differences between patients in high-risk and low-risk counties: drug type and dispenser type. In the graph, statistical significance is indicated next to the slope values as follows: ‘***’ for highly significant differences (<math display="inline"><semantics> <mrow> <mi>p</mi> <mo>≤</mo> <mn>0.001</mn> </mrow> </semantics></math>).</p>
Full article ">Figure 5
<p>Monthly per capita prescription differences between patients in high-risk and low-risk counties: dispenser type and prescriber location. In the graph, statistical significance is indicated next to the slope values as follows: ‘***’ for highly significant differences (<math display="inline"><semantics> <mrow> <mi>p</mi> <mo>≤</mo> <mn>0.001</mn> </mrow> </semantics></math>).</p>
Full article ">Figure 6
<p>Monthly per capita prescription differences between patients in high-risk and low-risk counties: drug type, dispenser type, and prescriber location. In the graph, statistical significance is indicated next to the slope values as follows: ‘***’ for highly significant differences (<math display="inline"><semantics> <mrow> <mi>p</mi> <mo>≤</mo> <mn>0.001</mn> </mrow> </semantics></math>), ‘*’ for significant differences (<math display="inline"><semantics> <mrow> <mi>p</mi> <mo>≤</mo> <mn>0.05</mn> </mrow> </semantics></math>).</p>
Full article ">
21 pages, 4331 KiB  
Article
Knowledge, Attitudes, and Practices of Antibiotic Use among Small-, Medium-, and Large-Scale Fish Farmers of the Stratum II of the Volta Lake of Ghana
by Samuel O. Dandi, Emmanuel D. Abarike, Seth M. Abobi, Dzigbodi A. Doke, Jan L. Lyche, Samuel Addo, Regina E. Edziyie, Amii I. Obiakara-Amaechi, Evensen Øystein, Stephen Mutoloki and Kofitsyo S. Cudjoe
Antibiotics 2024, 13(7), 582; https://doi.org/10.3390/antibiotics13070582 - 23 Jun 2024
Viewed by 595
Abstract
Background: Antibiotic residue in food products and the resulting antibiotic-resistant bacteria represent a significant global public health threat. The misuse of antibiotics is a primary contributor to this issue. This study investigated the knowledge, attitudes, and practices (KAP) regarding antibiotic use among cage [...] Read more.
Background: Antibiotic residue in food products and the resulting antibiotic-resistant bacteria represent a significant global public health threat. The misuse of antibiotics is a primary contributor to this issue. This study investigated the knowledge, attitudes, and practices (KAP) regarding antibiotic use among cage fish farmers on Ghana’s Volta Lake. Method: We conducted a cross-sectional survey with 91 cage fish farmers across three scales: small, medium, and large. A semi-structured questionnaire complemented by personal observations provided comprehensive data. We used several statistical methods for analysis: Pearson Chi-Square and Spearman correlation tests to examine relationships and trends among variables, logistic regression to analyze variable interactions, and Cronbach’s alpha to check internal consistency. Additionally, Kendall’s coefficient was used to rank challenges, utilizing STATA and SPSS for these calculations. Results: The survey revealed that 58.55% of cage fish farmers earn an average of 10,000 USD annually, with 35.16% having over 16 years of experience. From the survey, all sampled populations admitted to antibiotic applications in their farming operation. Knowledge of antibiotic types was mainly influenced by peers (46.15%), with tetracycline being the most recognized and used. There was a significant reliance on the empirical use of antibiotics, with 52.75% of farmers using them based on personal experience and 40.66% without a prescription. When initial treatments failed, 41.76% of the farmers would change or combine drugs. Older farmers (over 51 years) and those with tertiary education demonstrated significantly better KAP scores regarding antibiotic use. Strong correlations were also found among knowledge, attitudes, and practices in antibiotic usage. Conclusions: The findings indicate a need for improved education on antibiotic use among fish farmers to reduce misuse and enhance awareness of the potential consequences. This study provides foundational data for designing interventions to address these issues in the context of cage fish farming on Volta Lake. Full article
Show Figures

Figure 1

Figure 1
<p>Sources of information on antibiotics in fish farming.</p>
Full article ">Figure 2
<p>Information on specific antibiotics and their usage by fish farmers on Volta Lake.</p>
Full article ">Figure 3
<p>Factors that influence the desire of fish farmers to use antibiotics in fish culture.</p>
Full article ">Figure 4
<p>Farmers suggested ways of reducing the use of antibiotics in cage aquaculture.</p>
Full article ">Figure 5
<p>Cage fish farmers’ view on the role of antibiotics in fish health management.</p>
Full article ">Figure 6
<p>Precautions taken by cage farmers to prevent and manage diseases.</p>
Full article ">Figure 7
<p>Approaches used by farmers to address sudden change in fish behavior.</p>
Full article ">Figure 8
<p>Chemicals farmers use in treating and disinfecting their cage farms.</p>
Full article ">Figure 9
<p>Reasons why fish farmers use antibiotics in fish farming.</p>
Full article ">Figure 10
<p>Mode of application of antibiotics in fish culture on Volta Lake.</p>
Full article ">Figure 11
<p>Ways farmers judge the effectiveness and efficacy of antibiotics in fish farming.</p>
Full article ">Figure 12
<p>Map of the stratum II of the Volta Lake, Ghana showing the sampling site.</p>
Full article ">
20 pages, 682 KiB  
Article
Clinical Factors Associated with Binge-Eating Episodes or Purging Behaviors in Patients Affected by Eating Disorders: A Cross-Sectional Study
by Alice Caldiroli, Letizia Maria Affaticati, Sara Coloccini, Francesca Manzo, Alberto Scalia, Enrico Capuzzi, Davide La Tegola, Fabrizia Colmegna, Antonios Dakanalis, Maria Salvina Signorelli, Massimiliano Buoli and Massimo Clerici
J. Pers. Med. 2024, 14(6), 609; https://doi.org/10.3390/jpm14060609 - 7 Jun 2024
Viewed by 732
Abstract
The aim of the present study was to investigate the potential associations between clinical/socio-demographic variables and the presence of purging/binge-eating episodes in eating disorders (EDs). Clinical/socio-demographic variables and psychometric scores were collected. Groups of patients were identified according to the presence or absence [...] Read more.
The aim of the present study was to investigate the potential associations between clinical/socio-demographic variables and the presence of purging/binge-eating episodes in eating disorders (EDs). Clinical/socio-demographic variables and psychometric scores were collected. Groups of patients were identified according to the presence or absence of purging or objective binge-eating episodes (OBEs) and compared through t-test and chi-square tests. Binary logistic regression analyses were run. A sample of 51 ED outpatients was recruited. Patients with purging behaviors had a longer duration of untreated illness (DUI) (t = 1.672; p = 0.019) and smoked a higher number of cigarettes/day (t = 1.061; p = 0.030) compared to their counterparts. A lower BMI was associated with purging (OR = 0.881; p = 0.035), and an older age at onset showed a trend towards statistical significance (OR = 1.153; p = 0.061). Patients with OBEs, compared to their counterparts, were older (t = 0.095; p < 0.001), more frequently presented a diagnosis of bulimia or binge-eating disorder (χ2 = 26.693; p < 0.001), a longer duration of illness (t = 2.162; p = 0.019), a higher number of hospitalizations (t = 1.301; p = 0.012), and more often received a prescription for pharmacological treatment (χ2 = 7.864; OR = 6.000; p = 0.005). A longer duration of the last pharmacological treatment was associated with OBE (OR = 1.569; p = 0.046). In contrast to purging, OBE was associated with a more complicated and severe presentation of ED. A lower BMI and a later age at onset, as well as long-lasting previous pharmacological treatments, may predict the presence of purging/binging. Further research is needed to thoroughly characterize ED features and corroborate our preliminary findings. Full article
(This article belongs to the Section Disease Biomarker)
Show Figures

Figure 1

Figure 1
<p>Methodological steps of the present study.</p>
Full article ">
17 pages, 6705 KiB  
Article
Five-Year Evaluation of the PROA-NEN Pediatric Antimicrobial Stewardship Program in a Spanish Tertiary Hospital
by Aurora Fernández-Polo, Susana Melendo-Perez, Nieves Larrosa Escartin, Natalia Mendoza-Palomar, Marie Antoinette Frick, Pere Soler-Palacin and on behalf of the PROA-NEN Working Group
Antibiotics 2024, 13(6), 511; https://doi.org/10.3390/antibiotics13060511 - 30 May 2024
Viewed by 641
Abstract
Introduction: Actions to reduce and optimize antimicrobial use are crucial in the management of infectious diseases to counteract the emergence of short- and long-term resistance. This is particularly important for pediatric patients due to the increasing incidence of serious infections caused by resistant [...] Read more.
Introduction: Actions to reduce and optimize antimicrobial use are crucial in the management of infectious diseases to counteract the emergence of short- and long-term resistance. This is particularly important for pediatric patients due to the increasing incidence of serious infections caused by resistant bacteria in this population. The aim of this study was to evaluate the impact of a pediatric antimicrobial stewardship program (PROA-NEN) implemented in a Spanish tertiary hospital by assessing the use of systemic antimicrobials, clinical indicators, antimicrobial resistance, and costs. Methods: In this quasi-experimental, single-center study, we included pediatric patients (0–18 years) admitted to specialized pediatric medical and surgical units, as well as pediatric and neonatal intensive care units, from January 2015 to December 2019. The impact of the PROA-NEN program was assessed using process (consumption trends and prescription quality) and outcome indicators (clinical and microbiological). Antibiotic prescription quality was determined using quarterly point prevalence cross-sectional analyses. Results: Total antimicrobial consumption decreased during the initial three years of the PROA-NEN program, followed by a slight rebound in 2019. This decrease was particularly evident in intensive care and surgical units. Antibiotic use, according to the WHO Access, Watch and Reserve (AWaRe) classification, remained stable during the study period. The overall rate of appropriate prescription was 83.2%, with a significant increase over the study period. Clinical indicators did not substantially change over the study period. Direct antimicrobial expenses decreased by 27.3% from 2015 to 2019. Conclusions: The PROA-NEN program was associated with reduced antimicrobial consumption, improved appropriate use, and decreased costs without compromising clinical and/or microbiological outcomes in patients. Full article
(This article belongs to the Section Antibiotics Use and Antimicrobial Stewardship)
Show Figures

Figure 1

Figure 1
<p>Antibiotic prescription quality in cross-sectional analyses. Stacked bars show (<b>A</b>) the proportion of appropriate and inappropriate prescription rates, (<b>B</b>) the proportion of complete, incomplete, or no records, and (<b>C</b>) the proportion of appropriate and inappropriate prescribing according to record completeness (complete, incomplete, no records).</p>
Full article ">Figure 2
<p>Proportion of WHO AWaRe antimicrobial consumption. Stacked bars show the proportion of Access, Watch and Reserved antibiotics consumed (<b>A</b>) in each year of the study, and (<b>B</b>) across clinical units. N-ICU, neonatal intensive care unit; P-ICU, pediatric intensive care unit.</p>
Full article ">Figure 3
<p>Antimicrobial consumption over the study period. The graphs show (<b>A</b>) total antimicrobial, antibiotic, and antifungal consumption over the study period, (<b>B</b>) antibiotic consumption across clinical units, and (<b>C</b>) antifungal consumption across clinical units. Data are expressed as DOT/100PD. N-ICU, neonatal intensive care unit; P-ICU, pediatric intensive care unit.</p>
Full article ">Figure 4
<p>Proportion of antibiotics consumed over the study period. Stacked bars represent the annual proportion of each antibiotic class, both overall and by clinical unit. Antibiotic consumption is expressed as % DOT/100 PD and categorized using the ATC classification. N-ICU, neonatal intensive care unit; P-ICU, pediatric intensive care unit.</p>
Full article ">Figure 4 Cont.
<p>Proportion of antibiotics consumed over the study period. Stacked bars represent the annual proportion of each antibiotic class, both overall and by clinical unit. Antibiotic consumption is expressed as % DOT/100 PD and categorized using the ATC classification. N-ICU, neonatal intensive care unit; P-ICU, pediatric intensive care unit.</p>
Full article ">
21 pages, 1868 KiB  
Review
Exploring the Perioperative Use of DOACs, off the Beaten Track
by Fabiana Lucà, Fabrizio Oliva, Simona Giubilato, Maurizio Giuseppe Abrignani, Carmelo Massimiliano Rao, Stefano Cornara, Giorgio Caretta, Stefania Angela Di Fusco, Roberto Ceravolo, Iris Parrini, Adriano Murrone, Giovanna Geraci, Carmine Riccio, Sandro Gelsomino, Furio Colivicchi, Massimo Grimaldi and Michele Massimo Gulizia
J. Clin. Med. 2024, 13(11), 3076; https://doi.org/10.3390/jcm13113076 - 24 May 2024
Viewed by 619
Abstract
A notable increase in direct oral anticoagulant (DOAC) use has been observed in the last decade. This trend has surpassed the prescription of vitamin K antagonists (VKAs) due to the absence of the need for regular laboratory monitoring and the more favorable characteristics [...] Read more.
A notable increase in direct oral anticoagulant (DOAC) use has been observed in the last decade. This trend has surpassed the prescription of vitamin K antagonists (VKAs) due to the absence of the need for regular laboratory monitoring and the more favorable characteristics in terms of efficacy and safety. However, it is very common that patients on DOACs need an interventional or surgical procedure, requiring a careful evaluation and a challenging approach. Therefore, perioperative anticoagulation management of patients on DOACs represents a growing concern for clinicians. Indeed, while several surgical interventions require temporary discontinuation of DOACs, other procedures that involve a lower risk of bleeding can be conducted, maintaining a minimal or uninterrupted DOAC strategy. Therefore, a comprehensive evaluation of patient characteristics, including age, susceptibility to stroke, previous bleeding complications, concurrent medications, renal and hepatic function, and other factors, in addition to surgical considerations, is mandatory to establish the optimal discontinuation and resumption timing of DOACs. A multidisciplinary approach is required for managing perioperative anticoagulation in order to establish how to face these circumstances. This narrative review aims to provide physicians with a practical guide for DOAC perioperative management, addressing the most controversial issues. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

Figure 1
<p>Main clinical scores for arterial thromboembolic risk. CHF: congestive heart failure; AH: arterial hypertension; DM: diabetes mellitus; VD: vascular disease; TIA: transient ischemic attack; NT-proBNP: N-terminal pro–B-type natriuretic peptide; cTnI-hs: high-sensitivity cardiac troponin; INR: labile international normalized ratio; DBP: diastolic blood pressure; CKD: chronic kidney disease; CHD: coronary heart disease; PAD: peripheral artery disease; GFR: glomerular filtration rate.</p>
Full article ">Figure 2
<p>Caprini risk score for venous thromboembolic risk in surgical settings. CHF: congestive heart failure; DVT/PE: deep vein thrombosis/pulmonary embolism; BMI: body mass index; MI: myocardial infarction; COPD: chronic obstructive pulmonary disease.</p>
Full article ">Figure 3
<p>Main clinical scores for bleeding risk. INR: labile international normalized ratio; DBP: diastolic blood pressure; CHF: congestive heart failure; CHD: coronary heart disease; PAD: peripheral artery disease; DM: diabetes mellitus; CKD: chronic kidney disease; CLD: chronic liver disease; AH: arterial hypertension; TIA: transient ischemic attack; GFR: glomerular filtration rate.</p>
Full article ">Figure 4
<p>Key factors to take into consideration in the perioperative management of DOACs.</p>
Full article ">Figure 5
<p>Protocols for stopping and restarting DOAC therapy in planned interventions. Modified from Halvorsen S. et al. ESC Guidelines EHJ 2022 [<a href="#B5-jcm-13-03076" class="html-bibr">5</a>]. P.I.: planned intervention, O.D.: once daily; B.D.: twice daily; LMWH: low-molecular-weight heparin, DOAC: direct oral anticoagulant.</p>
Full article ">
13 pages, 910 KiB  
Article
Polysubstance Use among Maryland High School Students: Variations across County-Level School Districts
by Lindsey Webb, Kechna Cadet, Rashelle Musci, Shaheen Kurani, Laura K. Clary, Danielle German and Renee M. Johnson
Int. J. Environ. Res. Public Health 2024, 21(5), 639; https://doi.org/10.3390/ijerph21050639 - 17 May 2024
Viewed by 988
Abstract
Background: Polysubstance use is a highly prevalent public health issue, particularly among adolescents, and decisions on prevention programming and policies are often made at the local level. While there is a growing literature examining patterns of polysubstance use among adolescents, little is known [...] Read more.
Background: Polysubstance use is a highly prevalent public health issue, particularly among adolescents, and decisions on prevention programming and policies are often made at the local level. While there is a growing literature examining patterns of polysubstance use among adolescents, little is known about differences in those patterns across geographic regions. Methods: Using a large, representative sample of high school students from the state of Maryland (n = 41,091) from the 2018 Maryland Youth Risk Behavior Survey, we conducted a latent class analysis (LCA) of adolescent substance use along nine binary indicators, including past 30-day combustible tobacco, e-cigarette, alcohol, and cannabis use, as well as lifetime use of prescription opioids, cocaine, heroin, methamphetamine, and injection drug use. Measurement invariance across counties was examined using the Multiple Indicators and Multiple Causes (MIMIC) procedure. Results: The results of the LCA show three classes of adolescent substance use for the total sample: (1) low substance use, (2) commonly used substances (i.e., e-cigarette, alcohol, and cannabis use), and (3) polysubstance use. The results from the MIMIC procedure demonstrated geographic differences in students’ endorsement of specific indicators and their class membership. Conclusions: These differences demonstrate the need for an examination of local trends in adolescent polysubstance use to inform multi-tiered prevention programming and policy. Full article
(This article belongs to the Special Issue Prevention of High-Risk Behaviors in Adolescence)
Show Figures

Figure 1

Figure 1
<p>Model-estimated latent classes based on 3-class solution. Note: NMPO = non-medical prescription opioid use.</p>
Full article ">Figure 2
<p>Model-estimated latent class profiles based on 3-class multiple indicator multiple cause (MIMIC) LCA with county as source of DIF. Note: Interval bars are not included for heroin or methamphetamine as no significant DIF was identified for these indicators through the MIMIC modeling process. NMPO = non-medical prescription opioid use.</p>
Full article ">
12 pages, 1996 KiB  
Article
Survey on Actual Management of Osteoporosis with the Japanese Medical Data Vision Database in Elderly Patients Undergoing Spinal Fusion
by Kenta Yamamoto and Shunichi Tanaka
J. Clin. Med. 2024, 13(10), 2806; https://doi.org/10.3390/jcm13102806 - 10 May 2024
Cited by 1 | Viewed by 820
Abstract
Background: No actual data on spinal fusion and management of osteoporosis in Japan have been reported. The aim of the survey was to investigate pre- and post-operative management of osteoporosis, including testing and prescription, in elderly patients undergoing spinal fusion in Japan. Methods: [...] Read more.
Background: No actual data on spinal fusion and management of osteoporosis in Japan have been reported. The aim of the survey was to investigate pre- and post-operative management of osteoporosis, including testing and prescription, in elderly patients undergoing spinal fusion in Japan. Methods: Medical data on patients aged 65 years or older undergoing spinal fusion from April 2018 to March 2022 were extracted from the medical data vision (MDV) database containing health insurance claims data from Japanese acute care hospitals to investigate fusion area, pre- and post-operative osteoporosis tests (bone mineral density and osteoporosis markers), prescriptions of osteoporosis medications, and other information. Results: The analysis set consisted of 26,959 patients. Annual pre-operative BMD testing rates and osteoporosis markers testing rates were higher than the post-operative rates without significant annual changes. The post-operative prescription rate of osteoporosis medications throughout the target period was approximately two times higher than the preoperative rate. The drug with highest pre- and post-operative prescription rates was teriparatide (TPTD) followed by bisphosphonates, showing that the prescription rate of TPTD proportionally increased with the length of fusion area. Conclusions: It was suggested that patients aged 65 years or older undergoing spinal fusion might receive insufficient osteoporosis tests. Despite no trend in the testing rate with the length of fusion area, some tendency was observed in the selection of osteoporosis medications. In patients with osteoporosis undergoing spinal fusion, early examination, diagnosis, and therapeutic intervention may improve the prognoses, and solid testing and prescriptions are therefore expected. Full article
(This article belongs to the Section Orthopedics)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Annual changes in implementation rates of bone mineral density testing before and after surgery.</p>
Full article ">Figure 2
<p>Implementation rates of bone mineral density testing by fusion area before and after surgery.</p>
Full article ">Figure 3
<p>Annual changes in implementation rates of osteoporosis marker testing.</p>
Full article ">Figure 4
<p>Ratios of patients prescribed a therapeutic agent for osteoporosis before and after surgery. Patients who were prescribed a therapeutic agent for osteoporosis at least once during the target period within 360 days before and after surgery were specified as those prescribed with the applicable drug (unique specification).</p>
Full article ">Figure 5
<p>Annual changes in prescription rates of therapeutic agents for osteoporosis before and after surgery. Patients who were prescribed a therapeutic agent for osteoporosis at least once during the target period within 360 days before and after surgery were specified as those prescribed with the applicable drug (unique specification). In addition, post-operative days are divided into days 1–180 and 181–360.</p>
Full article ">Figure 6
<p>Patients who were prescribed a therapeutic agent for osteoporosis at least once during the target period within 360 days before and after surgery were regarded as those prescribed with the applicable drug.</p>
Full article ">
16 pages, 1606 KiB  
Article
Health Care Utilization for Common Shoulder Disorders: Analysis of the 2010–2019 National Patient Sample Data from the Health Insurance Review and Assessment Service in Korea
by Jin-Young Kang, Doori Kim, Huijun Kim, In-Hyuk Ha and Yoon Jae Lee
Medicina 2024, 60(5), 744; https://doi.org/10.3390/medicina60050744 - 29 Apr 2024
Cited by 1 | Viewed by 732
Abstract
Background and Objective: The aim of this study was to analyze trends in surgical and non-surgical service utilization for common shoulder disorders in Korea from 2010 to 2019. Methods and Materials: This retrospective, cross-sectional, descriptive study utilized National Patient Sample data from the [...] Read more.
Background and Objective: The aim of this study was to analyze trends in surgical and non-surgical service utilization for common shoulder disorders in Korea from 2010 to 2019. Methods and Materials: This retrospective, cross-sectional, descriptive study utilized National Patient Sample data from the Health Insurance and Review Assessment Service (HIRA) of Korea. These data constitute a 2% sample out of the entire Korean population and include data for a variety of parameters instrumental for health care research. Patients with at least one medical service use for rotator cuff syndrome or tear, impingement syndrome, or adhesive capsulitis between January 2010 and December 2019 were included. Trends in healthcare utilization by disorder type, patient demographics, seasonal service use, and treatment details were examined. Results: There was an upward trend in the total number of patients and costs for shoulder disorders, from 35,798 patients and USD 5,485,196 in 2010 to 42,558 and USD 11,522,543 in 2019, respectively. The number of patients aged ≥60 and hospital visits increased. March had the highest number of claims. Physical therapy was the most common non-surgical procedure, while nerve block claims more than doubled. Opioid prescription rates also tripled. Surgical treatments were dominated by shoulder rotator cuff repair and acromioplasty. Conclusions: There was a significant increase in healthcare utilization for shoulder disorders, marked by rising costs and patient numbers. The use of nerve blocks and opioids notably increased. These data are valuable for clinicians, researchers, and policymakers. Full article
Show Figures

Figure 1

Figure 1
<p>Flow chart of the inclusion of patient data.</p>
Full article ">Figure 2
<p>Ten-year (2010–2019) trend of health care utilization for the treatment of common shoulder disorders. (<b>A</b>) Number of patients in total and by shoulder disorder type, (<b>B</b>) medical costs in total and by shoulder disorder type.</p>
Full article ">Figure 3
<p>Ten-year (2010–2019) trend of health care utilization by type of shoulder disorder. (<b>A</b>) Percentage of patients aged 60 years or older by shoulder disorder type by year, (<b>B</b>) percentage of patients visiting hospitals (hospital-level medical institutions) by shoulder disorder type by year. Note: AC, adhesive capsulitis; IS, impingement syndrome; RCST, rotator cuff syndrome or tear.</p>
Full article ">Figure 4
<p>Ten-year (2010–2019) trend of medication use from claims data: opioids, NSAIDs, muscle relaxants, and systemic steroids.</p>
Full article ">
15 pages, 1288 KiB  
Article
Prevalence and Clinical Profile of Adults with ADHD Attending a Tertiary Care Hospital for Five Years
by Rabab Mohammed Bedawi, Yahya Al-Farsi, Hassan Mirza, Salim Al-Huseini, Tamadhir Al-Mahrouqi, Omaima Al-Kiyumi, Mohammed Al-Azri and Samir Al-Adawi
Int. J. Environ. Res. Public Health 2024, 21(5), 566; https://doi.org/10.3390/ijerph21050566 - 29 Apr 2024
Viewed by 1245
Abstract
(1) Objectives: This study aimed to assess the 5-year prevalence and clinical profile of attention deficit hyperactive disorder (ADHD) among adult patients seeking care in a tertiary care hospital in Oman. (2) Methods: The data were analysed using descriptive and inferential statistics and [...] Read more.
(1) Objectives: This study aimed to assess the 5-year prevalence and clinical profile of attention deficit hyperactive disorder (ADHD) among adult patients seeking care in a tertiary care hospital in Oman. (2) Methods: The data were analysed using descriptive and inferential statistics and standardised prevalence estimates were calculated. (3) Results: Of the 39,881 hospital visits, 1.77% were made by adults with ADHD. This is equivalent to 17.8 visits per 1000 outpatients. The year 2021 saw the highest prevalence among the five years considered, while 2020 had the lowest prevalence. Although the age distribution indicated that the age group ‘under 20’ had the highest prevalence, the gender distribution showed that ADHD was more common among adult men. Among the various subtypes of ADHD, inattention was the most common. (4) Conclusions: This study specifically compared the prevalence and associated factors between an adult cohort with ADHD and those other psychiatric clinic attendees during the same period. The study offers important information on the prevalence and clinical profile of adults with ADHD in the population under consideration. Full article
Show Figures

Figure 1

Figure 1
<p>Map of the Sultanate of Oman and its governorates. Adapted from the Anglo-Omani Society (<a href="https://images.app.goo.gl/1fDC8xuouzq2T3MB7" target="_blank">https://images.app.goo.gl/1fDC8xuouzq2T3MB7</a>, accessed on 20 February 2024).</p>
Full article ">Figure 2
<p>Distribution of prevalence estimates (per 1000 visits) of visits to adults diagnosed with ADHD by age category, Oman, 2018–2022.</p>
Full article ">Figure 3
<p>Distribution of the gender-specific prevalence (per 1000 visits) of adult attendees with the diagnosis of ADHD by age category.</p>
Full article ">Figure 4
<p>Governorate-specific estimates of the prevalence of standardised visits of adult attendees with the diagnosis of ADHD among all adult visits to the Department of Behavioural Medicine and Psychiatry over five years of follow-up, Oman, 2018–2022.</p>
Full article ">
22 pages, 2575 KiB  
Article
Quantitative and Longitudinal Assessment of Systemic Innate Immunity in Health and Disease Using a 2D Gene Model
by Hongxing Lei
Biomedicines 2024, 12(5), 969; https://doi.org/10.3390/biomedicines12050969 - 27 Apr 2024
Viewed by 813
Abstract
Dysregulation of innate immunity is deeply involved in infectious and autoimmune diseases. For a better understanding of pathogenesis and improved management of these diseases, it is of vital importance to implement convenient monitoring of systemic innate immunity. Built upon our previous works on [...] Read more.
Dysregulation of innate immunity is deeply involved in infectious and autoimmune diseases. For a better understanding of pathogenesis and improved management of these diseases, it is of vital importance to implement convenient monitoring of systemic innate immunity. Built upon our previous works on the host transcriptional response to infection in peripheral blood, we proposed a 2D gene model for the simultaneous assessment of two major components of systemic innate immunity, including VirSig as the signature of the host response to viral infection and BacSig as the signature of the host response to bacterial infection. The revelation of dysregulation in innate immunity by this 2D gene model was demonstrated with a wide variety of transcriptome datasets. In acute infection, distinctive patterns of VirSig and BacSig activation were observed in viral and bacterial infection. In comparison, both signatures were restricted to a defined range in the vast majority of healthy adults, regardless of age. In addition, BacSig showed significant elevation during pregnancy and an upward trend during development. In tuberculosis (TB), elevation of BacSig and VirSig was observed in a significant portion of active TB patients, and abnormal BacSig was also associated with a longer treatment course. In cystic fibrosis (CF), abnormal BacSig was observed in a subset of patients, and no overall change in BacSig abnormality was observed after the drug treatment. In systemic sclerosis-associated interstitial lung disease (SSc-ILD), significant elevation of VirSig and BacSig was observed in some patients, and treatment with a drug led to the further deviation of BacSig from the control level. In systemic lupus erythematosus (SLE), positivity for the anti-Ro autoantibody was associated with significant elevation of VirSig in SLE patients, and the additive effect of VirSig/BacSig activation was also observed in SLE patients during pregnancy. Overall, these data demonstrated that the 2D gene model can be used to assess systemic innate immunity in health and disease, with the potential clinical applications including patient stratification, prescription of antibiotics, understanding of pathogenesis, and longitudinal monitoring of treatment response. Full article
(This article belongs to the Section Immunology and Immunotherapy)
Show Figures

Figure 1

Figure 1
<p>Patterns of VirSig and BacSig activation in acute infection. (<b>A</b>) Top left, distinctive activation of VirSig and BacSig in the acute phase of viral or bacterial infection (GSE161731). (<b>B</b>) Top right, distinctive activation of VirSig and BacSig in the acute phase of viral or bacterial infection in another dataset (GSE176262). (<b>C</b>) Middle left, distinctive activation of BacSig in active infection (pharyngitis) or inactive colonization of group (<b>A</b>) <span class="html-italic">Streptococcus</span> (GSE158163). (<b>D</b>) Middle right, distinctive activation of BacSig at the acute or convalescent stage of Leptospirosis (GSE72946). The outcome of the patients at the acute phase was also indicated (dead or survivor). (<b>E</b>) Bottom left, persistent activation of VirSig and BacSig in some survivors of Ebola virus disease (GSE143549). (<b>F</b>) Bottom right, persistent activation of BacSig in some patients with chronic fatigue syndrome (GSE98139).</p>
Full article ">Figure 1 Cont.
<p>Patterns of VirSig and BacSig activation in acute infection. (<b>A</b>) Top left, distinctive activation of VirSig and BacSig in the acute phase of viral or bacterial infection (GSE161731). (<b>B</b>) Top right, distinctive activation of VirSig and BacSig in the acute phase of viral or bacterial infection in another dataset (GSE176262). (<b>C</b>) Middle left, distinctive activation of BacSig in active infection (pharyngitis) or inactive colonization of group (<b>A</b>) <span class="html-italic">Streptococcus</span> (GSE158163). (<b>D</b>) Middle right, distinctive activation of BacSig at the acute or convalescent stage of Leptospirosis (GSE72946). The outcome of the patients at the acute phase was also indicated (dead or survivor). (<b>E</b>) Bottom left, persistent activation of VirSig and BacSig in some survivors of Ebola virus disease (GSE143549). (<b>F</b>) Bottom right, persistent activation of BacSig in some patients with chronic fatigue syndrome (GSE98139).</p>
Full article ">Figure 2
<p>VirSig/BacSig features in healthy population. (<b>A</b>) Top panel, correlation of baseline VirSig or BacSig value with age among healthy adults (GSE186507). The blue line indicated linear regression. (<b>B</b>) Middle panel, baseline VirSig and BacSig values in different age groups (GSE231409). The age groups included 0–5 years old (A00–05Y), 5–10 years old (A05–10Y), 10–15 years old (A10–15Y), 15–20 years old (A15–20Y), and 20–90 years old (A20–90Y). (<b>C</b>) Bottom left, baseline BacSig/VirSig distribution in healthy males and females (GSE134080). (<b>D</b>) Bottom right, dynamic tuning of BacSig/VirSig during different stages of pregnancy (GSE108497). Pregnant women were divided into two groups, including the first 15 weeks of pregnancy (P01–15W) and the later phase of pregnancy (P16–40W).</p>
Full article ">Figure 2 Cont.
<p>VirSig/BacSig features in healthy population. (<b>A</b>) Top panel, correlation of baseline VirSig or BacSig value with age among healthy adults (GSE186507). The blue line indicated linear regression. (<b>B</b>) Middle panel, baseline VirSig and BacSig values in different age groups (GSE231409). The age groups included 0–5 years old (A00–05Y), 5–10 years old (A05–10Y), 10–15 years old (A10–15Y), 15–20 years old (A15–20Y), and 20–90 years old (A20–90Y). (<b>C</b>) Bottom left, baseline BacSig/VirSig distribution in healthy males and females (GSE134080). (<b>D</b>) Bottom right, dynamic tuning of BacSig/VirSig during different stages of pregnancy (GSE108497). Pregnant women were divided into two groups, including the first 15 weeks of pregnancy (P01–15W) and the later phase of pregnancy (P16–40W).</p>
Full article ">Figure 3
<p>Serial monitoring of BacSig/VirSig in tuberculosis. (<b>A</b>) Top panel, features of BacSig/VirSig in negative controls, latent TB patients (LTBI) and three types of active TB patients at diagnosis (GSE107995). The LTBI and control subjects were indicated by the types of their contacts. (<b>B</b>) Middle left, features of BacSig/VirSig in two groups of TB patients prior to treatment (GSE157657). Short_ATT stands for standard anti-tuberculosis treatment regimen, while long_ATT stands for longer treatment regimen. (<b>C</b>) Middle right, features of BacSig/VirSig in three groups of TB patients prior to anti-tuberculosis treatment (GSE89403). Cure_Fast stands for cure within 4 weeks. Cure_Slow stands for cure between 8–24 weeks. NoCure stands for drug resistance. (<b>D</b>) Bottom panel, serial monitoring of BacSig/VirSig during the twenty-four weeks of medical intervention (GSE89403). The samples were taken at diagnosis (DX), week one (W01), week four (W04), and week twenty-four (W24) after the initiation of anti-tuberculosis treatment.</p>
Full article ">Figure 4
<p>Serial monitoring of BacSig/VirSig in cystic fibrosis. (<b>A</b>) Upper panel, features of BacSig/VirSig in healthy controls, and CF patients before and after CFTR treatment (GSE124548). (<b>B</b>) Lower panel, changes in BacSig and VirSig in CF patients at the two time points (GSE124548). Base stands for baseline (prior to treatment). V2 stands for the second visit (six months later).</p>
Full article ">Figure 5
<p>Serial monitoring of BacSig/VirSig in SSc-ILD. (<b>A</b>) Top panel, features of BacSig/VirSig in healthy controls and SSc-ILD patients prior to CYC or MMF treatment (GSE181228). P_CYC and P_MMF indicated the two patient groups before treatment. (<b>B</b>) Middle panel, changes in BacSig and VirSig in SSc-ILD patients before and after the MMF treatment (GSE181228). (<b>C</b>) Bottom panel, changes in BacSig and VirSig in SSc-ILD patients before and after the CYC treatment (GSE181228). The two sampling points were baseline (before treatment) and month twelve (after the initiation of treatment).</p>
Full article ">Figure 6
<p>Serial monitoring of BacSig/VirSig in SLE. (<b>A</b>) Top panel, features of BacSig/VirSig in healthy controls and SLE patients with various anti-Ro levels (GSE72509). SLE_high stands for patients with high anti-Ro level. SLE_med stands for patients with medium anti-Ro level. SLE_none stands for patients with non-detectable anti-Ro. (<b>B</b>) Middle panel, dynamic changes in BacSig and VirSig in healthy women at different stages of pregnancy (GSE235508). (<b>C</b>) Bottom panel, dynamic changes in BacSig and VirSig in SLE patients at different stages of pregnancy (GSE235508). T1 through T3 stand for the three trimesters of pregnancy. T0 stand for non-pregnant stage. T4 through T6 stand for the postpartum time points (6 weeks, 6 months and 12 months).</p>
Full article ">
24 pages, 1669 KiB  
Review
Systematic Review of English/Arabic Machine Translation Postediting: Implications for AI Application in Translation Research and Pedagogy
by Lamis Ismail Omar and Abdelrahman Abdalla Salih
Informatics 2024, 11(2), 23; https://doi.org/10.3390/informatics11020023 - 22 Apr 2024
Viewed by 2721
Abstract
The twenty-first century has witnessed an extensive evolution in translation practice thanks to the accelerated progress in machine translation tools and software. With the increased scalability and availability of machine translation software empowered by artificial intelligence, translation students and practitioners have continued to [...] Read more.
The twenty-first century has witnessed an extensive evolution in translation practice thanks to the accelerated progress in machine translation tools and software. With the increased scalability and availability of machine translation software empowered by artificial intelligence, translation students and practitioners have continued to show an unwavering reliance on automatic translation systems. Academically, there is little recognition of the need to develop machine translation skillsets amongst translation learners in English/Arabic translation programs. This study provides a systematic review of machine translation postediting with reference to English/Arabic machine translation. Using the Preferred Reporting Items for Systematic Review and Meta-Analysis, the paper reviewed 60 studies conducted since the beginning of the twenty-first century and classified them by different metrics to identify relevant trends and research gaps. The results showed that research on the topic has been primarily prescriptive, concentrating on evaluating and developing machine translation software while neglecting aspects related to translators’ skillsets and competencies. The paper highlights the significance of postediting as an important digital literacy to be developed among Arabic translation students and the need to bridge the existing research and pedagogic gap in MT education. Full article
(This article belongs to the Special Issue Digital Humanities and Visualization)
Show Figures

Figure 1

Figure 1
<p>Study type/ranking frequency.</p>
Full article ">Figure 2
<p>Frequency of language-pair direction.</p>
Full article ">Figure 3
<p>MT engine frequency.</p>
Full article ">Figure 4
<p>Data frequency by text type.</p>
Full article ">Figure 5
<p>Literature distribution by publishing date.</p>
Full article ">Figure 6
<p>Approach and methods of the literature 2000-2023.</p>
Full article ">
13 pages, 2504 KiB  
Article
Clinical Impact of the Use of Warfarin in Patients with Atrial Fibrillation Undergoing Maintenance Hemodialysis
by Seok Hui Kang, Gui Ok Kim, Bo Yeon Kim, Eun Jung Son and Jun Young Do
J. Clin. Med. 2024, 13(8), 2404; https://doi.org/10.3390/jcm13082404 - 20 Apr 2024
Viewed by 647
Abstract
Background: We evaluated the impact of warfarin use on the clinical outcomes of patients with atrial fibrillation who were undergoing hemodialysis (HD). Methods: A retrospective analysis was conducted utilizing data from patients undergoing maintenance HD who participated in HD quality assessment [...] Read more.
Background: We evaluated the impact of warfarin use on the clinical outcomes of patients with atrial fibrillation who were undergoing hemodialysis (HD). Methods: A retrospective analysis was conducted utilizing data from patients undergoing maintenance HD who participated in HD quality assessment programs. Patients who were assigned the diagnostic code for atrial fibrillation (n = 4829) were included and divided into two groups based on the use of warfarin: No group (no warfarin prescriptions (n = 4009)), and Warfarin group (warfarin prescriptions (n = 820)). Results: Cox regression analyses revealed that the hazard ratio for all-cause mortality in the Warfarin group was 1.15 (p = 0.005) in univariate analysis and 1.11 (p = 0.047) in multivariable analysis compared to that of the No group. Hemorrhagic stroke was significantly associated with warfarin use, but no significant association between the use of warfarin and ischemic stroke or cardiovascular events was observed. The subgroup results demonstrated similar trends. Conclusions: Warfarin use is associated with a higher risk of all-cause mortality and hemorrhagic stroke, and has a neutral effect on ischemic stroke and cardiovascular events in patients with atrial fibrillation who are undergoing HD, compared to those who are not using warfarin. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

Figure 1
<p>Kaplan–Meier curves for all-cause mortality, hemorrhagic stroke, ischemic stroke, and cardiovascular events according to the use of warfarin. (<b>A</b>) All-cause mortality; (<b>B</b>) Hemorrhagic stroke; (<b>C</b>) Ischemic stroke; (<b>D</b>) Cardiovascular events. Abbreviations: CVE, cardiovascular events; Hstroke, hemorrhagic stroke; Istroke, ischemic stroke.</p>
Full article ">Figure 2
<p>Association between the use of warfarin and clinical outcomes using univariate Cox regression analyses based on subgroups. (<b>A</b>) All-cause mortality; (<b>B</b>) Ischemic stroke; (<b>C</b>) Hemorrhagic stroke; (<b>D</b>) Cardiovascular events. A low CHA<sub>2</sub>DS<sub>2</sub>-VAS<sub>C</sub> score was &lt;2 in females and &lt;3 in males, and a high CHA<sub>2</sub>DS<sub>2</sub>-VAS<sub>C</sub> score was ≥2 in females and ≥3 in males. The values represent the HR of the Warfarin group compared to the No group. Abbreviations: CI, confidence interval; HR, hazard ratio.</p>
Full article ">Figure 3
<p>Association between the use of warfarin and clinical outcomes using multivariable Cox regression analyses based on subgroups. (<b>A</b>) All-cause mortality; (<b>B</b>) Ischemic stroke; (<b>C</b>) Hemorrhagic stroke; (<b>D</b>) Cardiovascular events. A low CHA<sub>2</sub>DS<sub>2</sub>-VAS<sub>C</sub> score was &lt;2 in females and &lt;3 in males, and a high CHA<sub>2</sub>DS<sub>2</sub>-VAS<sub>C</sub> score was ≥2 in females and ≥3 in males. The values represent the HR of the Warfarin group compared to the No group. Abbreviations: CI, confidence interval; HR, hazard ratio.</p>
Full article ">
Back to TopTop